Please login to the form below

Not currently logged in
Email:
Password:

AstraZeneca's Alastair MacDonald joins ClinTec

Takes up role at the Scottish CRO as global head of clinical operations

ClinTec Alastair MacDonaldAlastair MacDonald has joined the Scottish contract research organsiation (CRO) ClinTec as its new global head of clinical operations.

He moves to the Glasgow-headquartered firm from AstraZeneca, where he spent nearly 15 years working in clinical development.

Most recently he served as the pharma company's global medical evidence and observational research director and has also previously spent six years on the board of the Institute of Clinical Research (ICR).

MacDonald said: “As global head of clinical operations at ClinTec, I look forward to meeting exciting challenges in delivering clinical research excellence as we continue to grow our capabilities throughout our already extensive geographical reach.

“Our current suite of programmes covers most therapeutic areas and, significantly, also includes complex projects in oncology and rare diseases that are intellectually and operationally challenging to deliver.”

Prior to his time at AstraZeneca, MacDonald served as a regional manager for SmithKline Beecham Pharmaceuticals (now GlaxoSmithKline) and at Danish firm Leo Pharmaceuticals.

ClinTec's chief operating officer Dr Robert Reekie said: “As our company enters its 20th year of significant organic growth, we are delighted to have attracted Alastair to ClinTec International and look forward to bringing his industry leading operational talent and high calibre to bear in providing complementary leadership to our award winning clinical research project teams. 

“In conjunction with our e-clinical technology platforms, this appointment further enhances our capability to meet and exceed the needs of our clients.”

22nd August 2016

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?
We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also...
CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...

Infographics